Remove email-newsletters
article thumbnail

STAT+: A preview of Intra-Cellular Therapies’ depression drug, and sizing up the MASH opportunity

STAT

I am one week away from the launch of my weekly email newsletter! What should you expect to see in my newsletter each week? Do you have a biotech-related question you want me to answer in the newsletter? Send me an email at BiotechScorecard@statnews.com. One catch: We need you to sign up, which you can do here.

226
226
article thumbnail

STAT+: A deep dive into Applied Therapeutics’ data, and questions on Cassava’s erased data

STAT

I’m launching a weekly email newsletter starting on March 28. What should you expect to see in my newsletter each week? I’m really excited to get started and I hope you’ll find the newsletter worthy of your inbox real estate. Have you heard the news? Plus, a few dashes of fun.

245
245
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

STAT+: Weed for weight loss, and more from Biotech Land

STAT

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. Luckily, this newsletter has arrived like a warm hug. Send me email at  BiotechScorecard@statnews.com. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox. I want to hear from you!

217
217
article thumbnail

STAT+: Argenx readies another blockbuster opportunity with its antibody drug

STAT

I’m launching a weekly email newsletter starting on March 28. What should you expect to see in my newsletter each week? Have you heard the news? It’s called Adam’s Biotech Scorecard and it’s exclusively for STAT subscribers. One catch: We need you to sign up, which you can do here.

278
278
article thumbnail

STAT+: Taking stock of the frenzied push into autoimmune disease

STAT

This is the online edition of Adam’s Biotech Scorecard, a new subscriber-only newsletter. Send me email at  BiotechScorecard@statnews. STAT+ subscribers can sign up here to get it delivered every Thursday to their inbox. Good morning! This is a magical time of the year in Boston, with trees in full bloom. I

223
223
article thumbnail

Is there a bigger move being planned at Cigna?

STAT

  STAT’s weekly newsletter  following the flow of money in medicine.  “I hope and pray that you will notice this email.” You’re reading the web version of Health Care Inc.,    Sign up  to get it in your inbox every Monday.  ambulance bill and needed help fighting it.

Hospitals 205
article thumbnail

STAT+: Pharmalittle: J&J agrees to settle talcum powder claims for $8.9 billion; FDA authorizes new severe-Covid therapy

STAT

Every time I sub in on this newsletter, I fear I will offend Ed and his readers’ fine-crafted coffee sensibilities with my plebeian choices. Good morning! Jason Mast here, filling in for Ed on this fine Passover eve.

190
190